Oscillating Light Therapy Could Help Treat Alzheimer's
|
By HospiMedica International staff writers Posted on 21 Dec 2016 |

Image: Aβ peptides in the mouse brain, after optogenetic stimulation, and following gamma oscillations (Photo courtesy of MIT).
Gamma frequency light therapy could attenuate amyloid load and modify microglia in Alzheimer’s disease (AD), claims a new study.
Researchers at the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA), Massachusetts General Hospital (MGH; Boston, USA), and other institutions conducted a study in mice genetically engineered to develop AD. Using optogenetics, the researchers induced gamma oscillations at 40 hertz in the hippocampus. After an hour of stimulation at 40 hertz, the researchers found that hippocampal levels of amyloid-β (Aβ) proteins fell by 40-50%; this effect was not observed at other frequencies.
The researchers then built a device comprised of a strip of light emitting diodes (LEDs) capable of being programmed to flicker at different frequencies and induce gamma oscillations in the brain when shone in the eyes. The flickering effect stimulates interneurons, cells that synchronize the gamma activity among brain cells to help them communicate with each other. The found, similarly, that one hour of exposure to the light flickering at 40 hertz set up gamma oscillations and halved Aβ levels in the visual cortex of mice in the early stages of AD; but the Aβ proteins returned to previous levels within 24 hours.
In further tests with longer exposure on mice in more advanced stages of Ad, the researchers found markedly reduced Aβ levels and plaque deposits. They also found that the gamma oscillations reduced another hallmark of AD, abnormal tau proteins that form tangles in the brain. Finally, the researchers also showed that gamma oscillations caused the induction of genes associated with morphological transformation of microglia, with histological analysis confirming increased microglia co-localization with Aβ. The study was published on December 7, 2016, in Nature.
“More research needs to be done before we can say if the therapy works for human patients with Alzheimer's disease,” said senior author professor Li-Huei Tsai, PhD, of MIT. “It's a big 'if',' because so many things have been shown to work in mice, only to fail in humans. But if humans behave similarly to mice in response to this treatment, I would say the potential is just enormous, because it's so noninvasive, and it's so accessible.”
Networks of neurons in the brain fire in a coordinated fashion, generating rhythmic waves of electric activity that occur at different frequencies. In the 20-50 Hz range, gamma oscillations are involved in memory encoding and retrieval, perception, and attention. Animal studies show that they serve to synchronize intercolumnar input in the cat visual cortex. Other studies in experimental animals also pointed to the role of gamma oscillations in spatial and working memory. Changes in these brain waves have been seen in several brain disorders, including in patients with AD.
Related Links:
Massachusetts Institute of Technology
Massachusetts General Hospital
Researchers at the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA), Massachusetts General Hospital (MGH; Boston, USA), and other institutions conducted a study in mice genetically engineered to develop AD. Using optogenetics, the researchers induced gamma oscillations at 40 hertz in the hippocampus. After an hour of stimulation at 40 hertz, the researchers found that hippocampal levels of amyloid-β (Aβ) proteins fell by 40-50%; this effect was not observed at other frequencies.
The researchers then built a device comprised of a strip of light emitting diodes (LEDs) capable of being programmed to flicker at different frequencies and induce gamma oscillations in the brain when shone in the eyes. The flickering effect stimulates interneurons, cells that synchronize the gamma activity among brain cells to help them communicate with each other. The found, similarly, that one hour of exposure to the light flickering at 40 hertz set up gamma oscillations and halved Aβ levels in the visual cortex of mice in the early stages of AD; but the Aβ proteins returned to previous levels within 24 hours.
In further tests with longer exposure on mice in more advanced stages of Ad, the researchers found markedly reduced Aβ levels and plaque deposits. They also found that the gamma oscillations reduced another hallmark of AD, abnormal tau proteins that form tangles in the brain. Finally, the researchers also showed that gamma oscillations caused the induction of genes associated with morphological transformation of microglia, with histological analysis confirming increased microglia co-localization with Aβ. The study was published on December 7, 2016, in Nature.
“More research needs to be done before we can say if the therapy works for human patients with Alzheimer's disease,” said senior author professor Li-Huei Tsai, PhD, of MIT. “It's a big 'if',' because so many things have been shown to work in mice, only to fail in humans. But if humans behave similarly to mice in response to this treatment, I would say the potential is just enormous, because it's so noninvasive, and it's so accessible.”
Networks of neurons in the brain fire in a coordinated fashion, generating rhythmic waves of electric activity that occur at different frequencies. In the 20-50 Hz range, gamma oscillations are involved in memory encoding and retrieval, perception, and attention. Animal studies show that they serve to synchronize intercolumnar input in the cat visual cortex. Other studies in experimental animals also pointed to the role of gamma oscillations in spatial and working memory. Changes in these brain waves have been seen in several brain disorders, including in patients with AD.
Related Links:
Massachusetts Institute of Technology
Massachusetts General Hospital
Latest Critical Care News
- Eye Imaging AI Identifies Elevated Cardiovascular Risk
- Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreSurgical Techniques
view channel
Fiber-Form Bone Graft Expands Intraoperative Options for Spinal Fusion
Spinal and orthopedic fusion procedures often require bone graft materials that handle predictably and support bone formation. Surgeons face added complexity in difficult anatomy and challenging fusion environments.... Read more
Ultrasound‑Aided Catheter Treatment Cuts Early Collapse in Pulmonary Embolism
Acute pulmonary embolism can cause rapid hemodynamic deterioration and early death in hospitalized and emergency patients. Systemic thrombolysis can dissolve clots but is limited by a high risk of major... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
Voice-Driven AI System Enables Structured GI Procedure Documentation
Documentation during gastrointestinal (GI) procedures often competes with real-time clinical decision-making and imposes a significant cognitive burden on physicians. Manual data entry and post-procedure... Read more
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







